This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A First Look at 'Real-World' Patch Users

C. Tracy Orleans, PhD; Nancy Resch, MEd; Elizabeth Noll; Martha K. Keintz, ScM; Barbara K. Rimer, DrPH; Theresa V. Brown, MPA; Thomas M. Snedden, MPA

JAMA. 1994;271(8):601-607.

Abstract
Objective.
—To assess transdermal nicotine use patterns and outcomes in a population of low-income older smokers.

Design.
—A 6-month telephone follow-up survey of smokers filling prescriptions for transdermal nicotine in the first 3 months of 1992.

Setting.
—Pennsylvania's Pharmaceutical Assistance Plan for the Elderly, the nation's largest state-level prescription plan for the elderly.

Population.
—A total of 1070 noninstitutionalized male and female smokers aged 65 through 74 years.

Main Outcome Measures.
—Self-reported physician/pharmacist advice and adjunctive treatments, concomitant smoking, and 6-month smoking abstinence.

Results.
—Respondents were predominantly long-term heavy smokers. They used nicotine patches for an average of 5 weeks, with few reporting use beyond 3 months or recalling bothersome side effects. Most of those with previous quit attempts rated quitting with the patch "easier." The 29% self-reported 6-month quit rate observed is encouraging. However, compliance with patch use guidelines was far from ideal in this high-risk population: only 54% of respondents received any initial advice or materials from their physicians or pharmacists, fewer than 2% took part in a formal clinic or one-to-one treatment program, and almost half (47%) smoked while using the patch, including 20% who smoked every day. Concomitant smoking was strongly associated with failure to achieve abstinence (P<.001). More frequent contact with physicians and/or pharmacists was associated with less concomitant smoking (P<.001) and higher quit rates (P=.005).

Conclusions.
—This survey offers an important first look at problems and prospects for nicotine patch therapy in older adults, with implications for other groups as well. Prospective studies are needed to clarify optimal treatment regimens and adjuncts.

(JAMA. 1994;271:601-607)

Author Affiliations
From the Fox Chase Cancer Center, Cheltenham, Pa (Dr Orleans and Mss Resch, Noll, and Keintz); the Duke Comprehensive Cancer Center, Durham, NC (Dr Rimer); and the Commonwealth of Pennsylvania Department of Aging, Harrisburg (Ms Brown and Mr Snedden). Drs Orleans and Rimer have received funding for clinical research, educational, and/or consulting activities from Ciba-Geigy Corp, Summit, NJ; Lederle Laboratories, Pearl River, NY; Marion Merrell Dow Inc, Kansas City, Mo; and Parke Davis Pharmaceutical Research Division, Morris Plains, NJ.

Footnotes
Reprint requests to Fox Chase Cancer Center, 510 Township Line Rd, Cheltenham, PA 19012 (Dr Orleans).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adherence to nicotine replacement therapy among pregnant smokers
Fish et al.
Nicotine Tob Res 2009;11:514-518.
ABSTRACT | FULL TEXT  

Smoking Cessation Intervention for Female Prisoners: Addressing an Urgent Public Health Need
Cropsey et al.
AJPH 2008;98:1894-1901.
ABSTRACT | FULL TEXT  

Characteristics of selectors of nicotine replacement therapy
Shiffman et al.
Tobacco Control 2005;14:346-355.
ABSTRACT | FULL TEXT  

Child Health Care Clinicians' Use of Medications to Help Parents Quit Smoking: A National Parent Survey
Winickoff et al.
Pediatrics 2005;115:1013-1017.
ABSTRACT | FULL TEXT  

Frequency of Physician-Directed Assistance for Smoking Cessation in Patients Receiving Cessation Medications
Solberg et al.
Arch Intern Med 2005;165:656-660.
ABSTRACT | FULL TEXT  

State-of-the-Art Interventions for Office-Based Parental Tobacco Control
Winickoff et al.
Pediatrics 2005;115:750-760.
ABSTRACT | FULL TEXT  

Training Future Pharmacists at a Minority Educational Institution: Evaluation of the Rx for Change Tobacco Cessation Training Program
Suchanek Hudmon et al.
Cancer Epidemiol. Biomarkers Prev. 2004;13:477-481.
ABSTRACT | FULL TEXT  

Impact of Over-the-Counter Sales on Effectiveness of Pharmaceutical Aids for Smoking Cessation
Pierce and Gilpin
JAMA 2002;288:1260-1264.
ABSTRACT | FULL TEXT  

Effect on Smoking Cessation of Switching Nicotine Replacement Therapy to Over-the-Counter Status
Thorndike et al.
AJPH 2002;92:437-442.
ABSTRACT | FULL TEXT  

New Developments in Smoking Cessation
Prochazka
Chest 2000;117 :169S-175S.
ABSTRACT | FULL TEXT  

Pharmacotherapy of Smoking Cessation
Okuyemi et al.
Arch Fam Med 2000;9:270-281.
ABSTRACT | FULL TEXT  

Computer tailored intervention for older smokers using transdermal nicotine
Orleans et al.
Tobacco Control 2000;9:i53-53.
FULL TEXT  

Does over-the-counter nicotine replacement therapy improve smokers' life expectancy?
Lawrence et al.
Tobacco Control 1998;7:364-368.
ABSTRACT | FULL TEXT  

Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacies
Shaw et al.
Tobacco Control 1998;7:161-167.
ABSTRACT | FULL TEXT  

National Patterns in the Treatment of Smokers by Physicians
Thorndike et al.
JAMA 1998;279:604-608.
ABSTRACT | FULL TEXT  

Childhood Poisoning Involving Transdermal Nicotine Patches
Woolf et al.
Pediatrics 1997;99:e4-e4.
ABSTRACT | FULL TEXT  

Use of Over-the-Counter Nicotine Patch for Smoking Cessation: Prudent or Premature?
McNagny and Ahluwalia
JAMA 1996;276:371-371.
ABSTRACT  

Use of Over-the-Counter Nicotine Patch for Smoking Cessation: Prudent or Premature?-Reply
Fiscella and Franks
JAMA 1996;276:371-372.
ABSTRACT  

Cost-effectiveness of the Transdermal Nicotine Patch as an Adjunct to Physicians' Smoking Cessation Counseling
Fiscella and Franks
JAMA 1996;275:1247-1251.
ABSTRACT  

Effectiveness of the 4-mg Dose of Nicotine Polacrilex for the Initial Treatment of High-Dependent Smokers
Sachs
Arch Intern Med 1995;155:1973-1980.
ABSTRACT  

Authors' reply
McMurray and Rankin
BMJ 1995;310:664-664.
FULL TEXT  

Using the Nicotine Patch to Stop Smoking-Reply
Fiore et al.
JAMA 1995;273:182-182.
ABSTRACT  

Using the Nicotine Patch to Stop Smoking
Swartz
JAMA 1995;273:181-181.
ABSTRACT  

Using the Nicotine Patch to Stop Smoking
Haxby and Toffler
JAMA 1995;273:181-182.
ABSTRACT  

Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation
Gourlay et al.
BMJ 1994;309:842-846.
ABSTRACT | FULL TEXT  

The Effectiveness of the Nicotine Patch for Smoking Cessation: A Meta-analysis
Fiore et al.
JAMA 1994;271:1940-1947.
ABSTRACT  

WHICH PATIENTS WITH NICOTINE PATCHES WILL QUIT SMOKING?
JWatch General 1994;1994:6-6.
FULL TEXT  

The Paradox of Tobacco Control
Satcher and Eriksen
JAMA 1994;271:627-628.
ABSTRACT